RNS Number : 0537O
itim Group PLC
13 May 2024
 

13 May 2024

 

itim Group plc

 

("itim" or "the Company" and together with its subsidiaries "the Group")

 

Full year results for the year ended 31 December 2023 and Notice of AGM

 

itim Group plc, a SaaS based technology company that enables store-based retailers to optimise their businesses to improve financial performance, is pleased to announce its audited results for the year ended 31 December 2023.

 

Financial Highlights

 

·     

Group revenues increased by 15 % to £16.1 million (2022: £14.0 million)

 

·     

Annual recurring revenue ("ARR") is £13.2 million (2022: £13.2 million)

 

·     

Group Adjusted EBITDA* £0.7 million (2022: £0.2 million) 

 

·     

Adjusted EBITDA* margin increased by 2 percentage points ("PPT") to 4% (2022: 2%)

 

·     

Adjusted Earnings per share** -2.86 pence (2022: -2.01 pence)

 

·     

Closing cash balances were £1.9 million at 31 December 2023, down from £3.9 million at 31 December 2022

 

* EBITDA has been adjusted to exclude share-based payment charges, exceptional items, along with depreciation, amortisation, interest and tax from the measure of profit.

** The profit measure has been adjusted to exclude exceptional items and share option charge

 

Ali Athar, Chief Executive, commented: "I am pleased to report itim's full year results which saw a strong increase in revenue fuelled by a 54% rise in services revenues and an 8% uptick in booked subscriptions. Our strategic investments have fortified our position and enhanced our products, paving the way for sustained success in the dynamic retail landscape. 

 

"Our commitment to excellence is evident in significant product improvements and the creation of 'UNIFY,' our unified retailing platform. As we navigate the evolving business environment, we are strategically realigning our focus to enhance financial performance and deliver tangible retail value. Looking ahead to 2024, itim's strategic focus on margin enhancement and operational efficiency provides the Board with cautious optimism and positions us well for continued success. I look forward to updating the market in due course."

 

Copies of the Annual Report and Accounts for FY2023 with the notice of annual general meeting have been posted to shareholders today and are available on the Company's website www.itim.com. The Company intends to hold its annual general meeting at the offices of the Company, 2nd Floor, Atlas House, 173 Victoria Street, London SW1E 5NA on 14th June 2024 at 10.30 a.m.

 

 

Enquiries:

 

Itim Group plc

Ali Athar, CEO

Ian Hayes CFO

 

0207 598 7700

WH Ireland (NOMAD & Broker)

Katy Mitchell

Harry Ansell

Darshan Patel

 

0207 220 1666

IFC Advisory

Graham Herring

Florence Chandler

0207 3934 6630

 

ABOUT ITIM

itim was established in 1993 by its founder, and current Chief Executive Officer, Ali Athar. itim was initially formed as a consulting business, helping retailers effect operational improvement. From 1999 the Company began to expand into the provision of proprietary software solutions and by 2004 the Company was focused exclusively on digital technology. itim has grown both organically and through a series of acquisitions of small, legacy retail software systems and associated applications which itim has redeveloped to create a fully integrated end to end Omni-channel platform.

 

 

CHAIRMAN'S STATEMENT

 

In this year's annual report, I am pleased to reflect on our journey, achievements, and the path forward for the Company.

 

I am proud to report that our financial performance has remained robust, showcasing the strength of our business model and team dedication. The past year has been a testament to our resilience and adaptability in the face of unprecedented challenges. Despite the persistent global uncertainties, the business has performed well and we have sustained growth, a testament to our prudent management and strategic foresight. We have remained steadfast in our commitment to delivering value to our shareholders, customers, employees, and communities. Our focus on innovation, operational excellence, and customer-centricity has driven us forward even in these turbulent times. We have continued to invest in research and development, to enhance our products, which we believe has kept us ahead of evolving market trends.

 

The strength of our existing client base is testament to the quality of our product offering and business as a whole. Our products demonstrate considerable worth and value to well renowned companies within the retail industry who continue to show trust and belief in the itim product suite. Demand for our offering remains high as we continue our long standing relationships and sign new business.

 

Furthermore, our commitment to sustainability and corporate responsibility remains strong. We prioritise

the importance of environmental stewardship, social impact, and ethical governance in today's interconnected world. We continue to promote diversity and inclusion, and foster a culture of integrity and transparency across our operations.

 

Looking ahead, we remain cautiously optimistic about the future. While uncertainties persist, we are confident in our ability to navigate challenges and seize opportunities. Innovation, agility, and resilience remain priorities to ensure we remain at the forefront of our industry and create sustainable value for all stakeholders.

 

I would like to express my sincere gratitude to our shareholders for their continued trust and support, to our customers for their loyalty and partnership, to our employees for their dedication and passion, and to our communities for their resilience and collaboration. Together, we will continue to build a brighter future for the Company.

 

 

Michael Jackson         

Chairman

10th May 2024

 

 

CHIEF EXECUTIVE'S REVIEW

 

I am pleased to present our Annual Report for 2023.

 

Our total revenue for the year reached £16.1 million in 2023, marking a 15% increase from the previous year's £14 million. This growth was driven by a robust 54% increase in services revenues and an 8% increase in booked subscription revenues, resulting in an uplift in EBITDA of over 200%.

As we approach the culmination of our two-year investment programme, the funds raised at IPO have not only fortified our financial position but have also played a pivotal role in enhancing our products and positioning us for sustained success in the dynamic retail landscape.

 

Our commitment to excellence is evident in the significant improvements across our product offerings. The inclusion of fashion into our core Retail Suite, catalysed by the Quiz Clothing contract win, marks a strategic milestone. Furthermore, investments in our Profimetrics platform, Chameleon store systems, Tradeledger for supplier collaboration, and e-commerce have collectively elevated the capabilities of our offerings.

 

This transformative journey has led to the creation of a unified platform, named 'UNIFY.' The rebranding not only consolidates our products, but also better communicates the essence of our Unified Retailing platform. The positive feedback from our customers underscores the tangible impact these improvements have made, reinforcing our confidence in our 'go-to-market' strategy.

As we confront the challenges of an ever-changing business environment, our commitment to sustaining and elevating our financial performance remains steadfast, underpinned by a solid recurring revenue base. Mindful of the current economic climate, we are currently in the process of "right sizing" our business, alongside a strategic pivot away from 'free' implementation services towards a continual focus on increasing services revenues and EBITDA.

 

Additionally, our consulting division continues to demonstrate the real 'benefits' of our solutions, underscoring our commitment to delivering tangible retail value to the retail community.

 

Looking ahead to 2024, itim's strategic focus centres on further enhancing margins and profitability, emphasising fine-tuning operational efficiency and ensuring sustainable returns on investments. Notably, the Company is now reallocating resources by reducing development spending and increasing efforts in sales and marketing.

 

The decision to pare back development spending is a strategic move, aimed at consolidating the gains made in product innovation, while actively shifting the spotlight to revenue generation. I believe this balanced approach positions itim for continued success and growth in the competitive business landscape.

 

As we navigate the challenges and opportunities of 2024, itim remains vigilant in monitoring market trends and consumer preferences. The Company's commitment to customer acquisition and retention, coupled with a strategic blend of innovation and revenue-focused initiatives, underpins our vision for sustained growth and prosperity in the years ahead.

 

In conclusion, I want to express my gratitude for your continued trust and support. As we stand at the threshold of a new chapter, poised for sustained growth.

 

Ali Athar          
Chief Executive officer

10th May 2024



 

CHIEF FINANCIAL OFFICER'S REVIEW

 

Income Statement

 

Overview

In 2023, Itim embarked on a strategic realignment, shifting its business focus from subscription growth to prioritising EBITDA and cash flow through driving services revenues. This shift reflected a proactive response to the current global uncertainties, and to adapt to the prevailing market conditions.

 

The early indicators of this strategic shift are encouraging, with EBITDA increasing to £0.7m, marking a significant increase from the £0.2m reported in 2022. Although the transition will take time, I am pleased that we are already seeing an upward shift in profitability.

 

Revenue

Revenues for the year were £16.1 up from £14m in 2022, an increase of 15%. This was largely due to an increase of services revenues of 54% along with an increase in booked subscription revenues of 8%.

 

With the shift in business focus, Annual Recurring Revenue (ARR) remained static at £13.2m at the year-end (2022: £13.2m). Despite the shift towards driving services revenues, the quality and certainty of recurring revenues as a percentage of total turnover remained high at 79% (2022: 84%).

 

Gross profit

The gross profit margin remained flat in 2023 as our development capability was fully engaged in delivering the fashion product into the platform for the February 2024 release. While this intensive effort did not drive substantial services revenues in the year, we view this effort as an additional pillar for future success.

 

Furthermore we currently have excess capacity in our hosting environment that will be utilised as new subscription revenues are on boarded to the hosting infrastructure which will contribute to improving margins without incurring additional costs for the Company.

 

Additionally in response to the prevailing economic environment, we recognise the importance of aligning our resources with market conditions. Therefore, we are proactively undertaking a rightsizing strategy for the business. This initiative aims to ensure that our headcount is optimised for efficiency and to navigate the current economic landscape.

 

With the initiatives outlined above we anticipate that the gross margin percentage will improve over time.

 

Administrative expenses

The administrative cost base increased by a marginal 1.7% over 2022. As a percentage of sales, administrative expenses have decreased from 31% in 2022 to 27% in 2023 and we only anticipate large fluctuations in overhead costs due to increased marketing spend.

 

Foreign exchange rates

With 33% of 2023 revenues denominated in foreign currencies, the table below sets out the percentage of annual contracts in the foreign currencies we trade in and the impacts of those foreign currencies at the Balance Sheet date and the average movements over the course of the year for P&L purpose.

FX Rates

31-Dec-22

31-Dec-23

2023

2022 Average

2023 Average

2023

(% of ARR at year end)

FX rate

FX rate

Variance %

FX rate

FX rate

Variance %

£GBP/Euro (ARR 7%)

1.129

1.153

2%

1.15

1.149

0%

£GBP/BRL (ARR 18%)

6.386

6.180

-3%

6.389

6.209

-3%

£GBP/USD (ARR 8%)

1.209

1.273

5%

1.238

1.243

0%

 

 

Foreign exchange rates have remained relatively static during the year with minimal volatility of Sterling against all our functional currencies throughout the year and at the year end.

 

Taxation

The Group continues to take advantage of R&D tax credits as it continues to innovate its technology offering. The current year tax credit is made of up of a net current tax credit of £0.34m (2022: £0.62m) and a deferred tax charge of £0.13m (2022: £0.03m).

 

Earnings/(Loss) per share

Basic EPS for the year was -2.86p (2022: -2.2p) and the diluted EPS was -2.86p (2022: -2.2p).

On an adjusted profit basis after adjusting for exceptional items and the share option charge the adjusted earnings basic EPS was -2.86p (2022: -2.01p) and the adjusted earnings diluted EPS was -2.86p (2022: -2.01p).

 

Dividend

The Board does not propose to pay a dividend in respect of the financial year (2022: £nil).

 

Group Statement of Financial position

The Group had net assets of £11.5m at 31st December 2023 (2022: £12.5m) a decrease of £1m attributable to the loss for the year.

 

Cash flow and working capital

The Group ended the year with a cash balance of £1.9m (2022: £3.9m).

 

Cash generated from operating activities for the year amounted to £0.53m (2022: £0.48m). There were no further inflows from investing activities during the year (2022: £nil). Cash expended on capitalised product development was £1.9m (2022: £2.1m) payment of interest, lease liabilities and equipment amounted to £0.6m (2022: £0.5m). No loans were made in the year (2022: £0.1m). Which taken together with our opening cash balance of £3.9m gives the closing cash balance at the year-end.

 

Equity

There were no changes in equity during the year.

 

Ian Hayes        

Chief Financial Officer 

10th May 2024

 



 

Consolidated Statement of Profit or Loss and Other Comprehensive Income

For the year ended 31 December 2023

 






Total


Total


Note




2023


2022






£'000


£'000









Revenue

4,5




16,130


14,034

Cost of sales





(11,090)


(9,538)









Gross profit





5,040


4,496









Administrative expenses





(4,356)


(4,285)









EBITDA





684


211









Amortisation of intangible assets

12




(1,146)


(889)

Share option charge

23




-


(58)

Depreciation

13




(49)


(42)

Depreciation of right-of-use/HP assets

19,13




(545)


(452)









Loss from operations





(1,056)


(1,230)









Other interest





(41)


(45)









Loss on ordinary activities before taxation

6




(1,097)


(1,275)









Taxation

10




205


589









Loss for the year





(892)


(686)









Other comprehensive income








Exchange differences on retranslation of foreign operations





(56)


124









Total comprehensive loss for the year net of tax



(948)


(562)









Loss per Share








Basic

11




(2.86)p


(2.20)p

Diluted

11




(2.86)p


(2.20)p

 

 

All comprehensive income for continuing operations is shown above.

The notes form part of these financial statements.

 



 

Consolidated Statement of Changes in Equity

For the year ended 31 December 2023

 




Share

Capital

Foreign

Retained



Share

Share

options

redemption

exchange

profits/



capital

premium

reserve

reserve

reserve

(losses)

Total


£'000

£'000

£'000

£'000

£'000

£'000

£'000









At 1 January 2022

1,561

7,398

455

1,103

26

2,438

12,981

Comprehensive income for the year

-

-

-

-

-

(686)

(686)

Foreign exchange movement

-

-

-

-

124

-

124

Total comprehensive income

-

-

-

-

124

(686)

(562)

Share option charge

-

-

58

-

-

-

58

At 31 December 2022

1,561

7,398

513

1,103

150

1,752

12,477

Comprehensive income for the year

-

-

-

-

-

(892)

(892)

Foreign exchange movement

-

-

-

-

(56)

-

(56)

Total comprehensive income

-

-

-

-

(56)

(892)

(948)

At 31 December 2023

1,561

7,398

513

1,103

94

860

11,529

 

The notes form part of these financial statements.

 



 

Consolidated Statement of Financial Position

 As at 31 December 2023

 

Note

     

2023

      £'000

     

2022

      £'000

Non-current assets






Intangible assets

12


11,109


10,069

Plant and equipment

13


476


721

Right-of-use assets

19


1,058


442

Deferred tax

10


13


164

Total non-current assets



12,656


11,396

Current assets






Trade and other receivables

15


5,385


4,603

Cash and cash equivalents



1,930


3,922

Total current assets



7,315


8,525

Total assets



19,971


19,921

Current liabilities






Trade and other payables

16


(6,398)


(5,776)

Right-of-use liability

19


(287)


(297)

Total current liabilities



(6,685)


(6,073)

Non-current liabilities






Trade and other payables due in more than one year

17


(347)


(540)

Right-of-use liability

19


(795)


(201)

Deferred tax

10


(615)


(630)

Total non-current liabilities



(1,757)


(1,371)

Total liabilities



(8,442)


(7,444)

Net assets



11,529


12,477

Capital and reserves






Called up share capital

21


1,561


1,561

Share premium account

22


7,398


7,398

Share options reserve

22


513


513

Capital redemption reserve

22


1,103


1,103

Foreign exchange reserve

22


94


150

Retained profit

22


860


1,752

Shareholders' funds



11,529


12,477

 

These financial statements were approved and authorised for issue by the Board of Directors on 10th May 2024.

Signed on behalf of the Board of Directors       

I D Hayes

Director

The notes form part of these financial statements.

 



 

Company Statement of Financial Position

As at 31 December 2023

 

Note

     

2023

£'000


2022

£'000

Non-current assets






Intangible assets

12


350


-

Plant and equipment

13


374


647

Investments

14


5,071


5,071

Right-of-use assets

19


551


-

Total non-current assets



6,346


5,718

Current assets






Trade and other receivables

15


15,491


13,774

Cash and cash equivalents



140


1,041

Total current assets



15,631


14,815

Total assets



21,977


20,533

Current liabilities






Trade and other payables

16


(827)


(647)

Deferred tax

10


(72)


(84)

Right-of-use liability

19


(131)


-

Total current liabilities



(1,030)


(731)

Non-current liabilities






Trade and other payables due in more than one year

17


(347)


(540)

Right-of-use liability

19


(414)


-

Total non-current liabilities



(761)


(540)

Total liabilities



(1,791)


(1,271)

Net assets



20,186


19,262

Capital and reserves






Called up share capital

21,24


1,561


1,561

Share premium account

22,24


7,398


7,398

Share options reserve

22,24


513


513

Capital redemption reserve

22,24


1,103


1,103

Retained profit

22,24


9,611


8,687

Shareholders' funds



20,186


19,262

 

These financial statements were approved and authorised for issue by the Board of Directors on 10th May 2024.            

Signed on behalf of the Board of Directors

I D Hayes         

Director

The notes form part of these financial statements.

 



 

Consolidated Cash Flow Statement

Year ended 31 December 2023

 

Note


2023

£'000

2022

£'000

Cash flows from operating activities





Loss after taxation



(892)

(686)

 





Adjustments for:





Taxation

10


(205)

(589)

Share option charge

23


-

58

Other interest on leases

19


41

45

Amortisation and depreciation

12,13,19


1,740

1,383

Cash flows from operations before changes in working capital



684

 

211

 

Movement in trade and other receivables

15


(1,297)

(384)

Movement in trade and other payables

16


678

371

Cash generated from operations



65

198

Corporation tax



462

280

Net cash flows from operating activities



527

478

 





Cash flows from investing activities





Capital expenditure on intangible assets

12


(1,870)

(2,140)

Purchase of plant and equipment

13


(77)

(49)

Stamp duty on ROU lease renewal



(6)

-

Net cash flows from investing activities



(1,953)

(2,189)






Interest repayments

18


(16)

-

Payment of lease liabilities

19


(528)

(438)

Loan issued

15


-

(140)

Net cash flows from financing activities



(544)

(578)

 

 

 

 

 

Net decrease in cash and cash equivalents



(1,970)

(2,289)

Cash and cash equivalents at beginning of year



3,922

6,172

Exchange (losses)/gains on cash and cash equivalents

28


(22)

39

Cash and cash equivalents at end of year



1,930

3,922

 

The notes form part of these financial statements.

 



 

Company Cash Flow Statement

Year ended 31 December 2023

 


2023

£'000

2022

£'000





Cash flows from operating activities




Profit after taxation


924

592

Adjustments for:




Taxation

10

(12)

139

Depreciation

13

273

170

Finance costs


18

15

Finance income


(49)

(25)

Share option charge

23

-

58

Cash flows from operations before changes in working capital


1,154

949

Movement in trade and other receivables

15

(2,016)

(2,895)

Movement in trade and other payables

16

190

-

Cash generated from operations


(672)

(1,946)

Finance income


-

25

Net cash flows from operating activities


(672)

(1,921)

Cash flows from investing activities




Stamp duty on ROU lease renewal


(6)

-

Net cash flows from investing activities


(6)

-

Cash flows from financing activities




Interest paid

18

(16)

-

Payment of lease liability


(207)

(107)

Loan issued

15

-

(140)

Net cash flows from financing activities


(223)

(247)

Net decrease increase in cash and cash equivalents


(901)

(2,168)

Cash and cash equivalents at beginning of year


1,041

3,209

Cash and cash equivalents at end of year


140

1,041

 

The notes form part of these financial statements.

 



 

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

1. Corporate Information

The consolidated financial statements of ITIM Group plc and its subsidiaries (collectively, the Group) for the year ended 31 December 2023 were authorised for issue in accordance with a resolution of the directors on 10th May 2024. itim Group plc ("the Company") is a public limited company incorporated and domiciled in the UK. The nature of the operations and principal activities of the Company and its subsidiary undertakings (the "Group") are set out in the Strategic Report on pages 5 to 11 and the Directors' report on pages 25 to 28.

 

2. Basis of preparation

The consolidated financial statements of the Group are prepared under IFRS and International Financial Reporting Interpretations Committee ("IFRIC") interpretations in accordance with International Accounting Standards in conformity with the requirements of the Companies Act 2006 applicable to companies reporting under IFRS.

 

The Company's financial statements have been prepared under IFRS and International Financial Reporting Interpretations Committee ("IFRIC") interpretations in accordance with International Accounting Standards in conformity with the requirements of the Companies Act 2006 and as permitted by section 408 of the Companies Act 2006, no income statement is presented for the company. The Company made a profit of £923,983 for the year ended 31 December 2023 (2022: £591,650)

 

The financial statements are presented in GBP, which is also the company's functional currency.

Amounts are rounded to the nearest thousand, unless otherwise stated.

The financial statements have been prepared on the going concern basis.

 

3. Summary of significant accounting policies

Basis of consolidation

The Group financial statements consolidate the financial statements of the company and its subsidiary undertakings drawn up to 31 December each year. The results of subsidiaries acquired or sold are consolidated for the periods from or to the date on which control passed. Acquisitions are accounted for under the acquisition method.

 

Subsidiaries

Subsidiaries are all entities over which the Group has the ability to exercise control and are accounted for as subsidiaries. The results of subsidiaries are included in the Group income statement from the date of acquisition until the date that such control ceases. Intercompany transactions and balances between Group companies are eliminated upon consolidation.

 

Revenue recognition

Revenue was recognised to the extent that it was probable that the economic benefits would flow to the Group and the revenue could be reliably measured.

Revenue represents the amounts (excluding value added tax) derived from the provision of goods and services to third party customers during the year by the group. Revenue is derived from the Group's principal activity and excludes VAT.

The Group derives revenue from two principal sources as noted below:

Recurring revenue

 

1. Recurring revenue consists of:

·      Subscriptions - revenue from subscriptions derive from the Group's hosted software-as-a-service subscription application, which allows customers to use hosted software over the contract period without taking possession of the software. Revenue is recognised over the contract period, commencing on the date of the service go live which gives the customer the right-to-use and access the platform.

·      Support and maintenance - derive from support services and software upgrades offered to customers using the Group's software products. Revenue is recognised over the contract period, commencing on the go-live date of the implementation which gives the customer the right to access support services and the right to receive upgrades.

 

2. One off revenue

One off revenue consists of:

·      Licences - the performance obligation for the provision of licences is considered to be satisfied when the agreement is signed by the customer and they are given access to the related software intellectual property ("IP") without any requirement to provide updates. It is recognised in full at the transaction price and over the period of implementation before the go live date of the implementation.

·      Services - Services revenue relate to design and implementation services for each customer. Services enhance an asset that the customer controls and the Group creates specific fit for purpose assets which cannot be used elsewhere. The transaction price is the amount determined by fixed price contracts or on a time and materials basis where the Group has a right for consideration for work performed to date. Under the terms of the contracts, the Group has a right to invoice at the achievement of various milestones in the contract.

·      Services are recognised over time and management consider the time spent as a proportion of total time expected is the most appropriate basis for recognition of this revenue stream as staff time is the main input into the delivery of the service. Any differences to the revenue measured by the above method and the amounts invoiced are included in the balance sheet. Further information on the contracts assets or contract liabilities are included in note 4.

 

Intangible assets - Goodwill

Goodwill is not amortised but tested for impairment annually and whenever impairment indicators require. In most cases the Group identified its cash generating units as one level below that of an operating segment. Cash flows at this level are substantially independent from other cash flows and this is the lowest level at which goodwill is monitored. A goodwill impairment loss is recognised in the Statement of Comprehensive Income whenever and to the extent that the carrying amount of a cash-generating unit exceeds the unit's recoverable amount, which is the greater of value in use and fair value less cost to sell.

Negative goodwill relating to intangible fixed assets requires immediate recognition in the Statement of Comprehensive Income. 

 

In calculating goodwill, the total consideration, both actual and deferred, is taken into account. Where the deferred consideration is contingent and dependent upon future trading performance, an estimate of the present value of the likely consideration payable is made. This contingent consideration is re-assessed annually.  The difference between the present value and the total amount payable at a future date gives rise to a finance charge which is charged to the Statement of Comprehensive Income and credited to the liability over the period in which the consideration is deferred.  The discount used approximates to market rates.

 

Intangible assets - research and development expenditure

Research expenditure is written off as incurred. Internally generated development expenditure is also written off, except where the directors are satisfied as to the technical, commercial and financial viability of individual projects. In such cases, the identifiable expenditure is capitalised and amortised over the period during which the group is expected to benefit. This period is seven years. Provisions are made for any impairment.

 

Intangible assets - other

Other intangible assets recognised in these financial statements consist of Customer contracts and relationships and Intellectual Property Rights acquired on the acquisition of EDI Plus Limited along with the purchase of the intellectual property rights of software.

 

Amortisation is calculated to write off their cost or valuation less any residual value over their estimated useful lives as follows:

 

Customer contracts and relationships - straight line over 10 years

Intellectual Property Rights - straight line over 10 years

Intellectual property rights of software - straight line over 7 years

 

The amortisation of intangible fixed assets is shown as a separate line in the Consolidated Statement of Comprehensive Income.

 

The carrying values of intangible assets are reviewed for impairment whenever events or changes in circumstances indicate the carrying value may not be recoverable.

 

Impairment non-current assets

For the purposes of impairment testing, goodwill is allocated to each of the Group's cash-generating units. A cash-generating unit to which goodwill has been allocated is tested for impairment annually, or more frequently when there is an indication that the unit may be impaired. If the recoverable amount of the cash-generating unit is less than its carrying amount, the impairment loss is allocated first to reduce the carrying amount of any goodwill allocated to the unit and then to the other assets of the unit pro-rata based on the carrying amount of each asset in the unit.

 

Any impairment loss for goodwill is recognised directly in profit or loss. An impairment loss recognised for goodwill is not reversed in subsequent periods.

 

Foreign currencies

Transactions denominated in a foreign currency are translated into sterling at the rate of exchange ruling at the date of the transaction.  At the balance sheet date, monetary assets and liabilities denominated in foreign currency are translated at the rate ruling at that date.  All exchange differences are dealt with in the Statement of Comprehensive Income.

 

Non-monetary items that are measured in terms of historical cost in a foreign currency are translated using the exchange rates as at the dates of the initial transactions. Non-monetary items measured at fair value in a foreign currency are translated using the exchange rates at the date when the fair value is determined. The gain or loss arising on translation of non-monetary measured at fair value is treated in line with the recognition of gain or loss on change in fair value in the item.

 

For consolidation purposes, the assets and liabilities of overseas subsidiary undertakings are translated at the functional currency at the rate of exchange ruling at the reporting date.  Profit and loss accounts of such undertakings are consolidated at the average rate of exchange during the year.  Exchange differences arising are included in a separate component of equity.

 

Plant and equipment

Plant and equipment is carried at cost less accumulated depreciation and any recognised impairment in value. Cost comprises the aggregate amount paid to acquire asset and includes costs directly attributable to making the asset capable of operating as intended.

 

Depreciation of plant and equipment is calculated to write off their cost or valuation less any residual value over their estimated useful lives as follows:

 

Computer equipment - straight line over 3 years

Office equipment - straight line over 3 years

Fixtures and fittings - straight line over 3 years

 

The assets' residual values, useful lives and methods of depreciation are reviewed, and adjusted if appropriate on an annual basis. An asset is de-recognised upon disposal or when no future economic benefits are expected from its use or disposal. Any gain or loss arising on de-recognition of the asset (calculated as the difference between the net disposal proceeds and the carrying amount of the asset) is included in the income statement in the period that the asset is derecognised. The carrying values of tangible fixed assets are reviewed for impairment in periods if events or changes in circumstances indicate the carrying value may not be recoverable.

 

Fixed asset investments

Subsidiaries are measured at cost less impairment.

Investments are reviewed for impairment at the end of the first full financial year following the acquisition and in other periods if events or changes in circumstances indicate that the carrying value may not be recoverable. Provision is made for any impairment.

 

Trade and other receivables

Trade and other receivables are initially stated at their fair value plus transaction costs, then subsequently at amortised cost using the effective interest method if applicable, less impairment losses. Provisions against trade and other receivables are made when there is objective evidence that the Group will not be able to collect all amounts due to them in accordance with the original terms of those receivables. The amount of the write down is determined as the difference between the asset's carrying amount and the present value of estimated future cash flows.

 

Cash and cash equivalents

Cash and cash equivalents comprise cash at bank and short-term deposits with an original maturity of three months or less. Bank overdrafts that are repayable on demand and form an integral part of cash management are included as components of cash and cash equivalents for the purposes of the cash flow statement.

 

Trade and other payables

Trade and other payables are recognised at original cost.

 

Loans and borrowings

Loans and borrowings are recorded at amortised cost using the effective interest method, with interest-related charges recognised as an expense in finance cost in the statement of comprehensive income.

 

Leases - as a lessee

Assets and liabilities arising from a lease are initially measured on a present value basis. Lease liabilities include the net present value of fixed lease payments. The lease payments are discounted using the interest rate implicit in the lease. If that rate cannot be readily determined, the lessee's incremental borrowing rate is used, being the rate that the lessee would have to borrow the funds necessary to obtain an asset of similar value to the right-of-use asset with similar terms, security and conditions.

 

Lease payments are allocated between principal and finance costs. The finance cost is charged to profit or loss over the lease period so as to produce a constant periodic rate of interest on the remaining balance of the liability for each period.

 

Right-of-use assets are measured at cost comprising the initial measurement of lease liability, any lease payments made at or before the commencement date less any lease incentives received, and any initial direct costs.

 

Right-of-use assets are depreciated over the shorter of the asset's useful life and the lease term on a straight-line basis.

 

Payments associated with low-value items and leases of a duration less than 1 year are recognised as an expense in profit or loss on a straight-line basis.

 

Income taxes

Current income tax assets and liabilities for the current period are measured at the amount expected to be recovered from or paid to the taxation authorities based on the tax rates and tax laws used to compute the amount are those that are enacted or substantively enacted by the balance sheet date.

Deferred tax is provided using the liability method on temporary differences between the tax bases of assets and liabilities and their carrying amounts for financial reporting purposes at the reporting date. Deferred tax is calculated on an undiscounted basis at the tax rates that are expected to apply in the period when the liability is settled based on the tax rates and tax laws enacted or substantively enacted by the balance sheet date.

 

 

Deferred tax liabilities are recognised for all taxable temporary differences, except when the deferred tax liability arises from the initial recognition of goodwill or an asset or liability in a transaction that is not a business combination and, at the time of the transaction, affects neither the accounting profit nor taxable profit or loss.

 

Deferred tax assets are recognised for all deductible temporary differences, carry forward of unused tax credits and unused tax losses, to the extent that it is probable that taxable profit will be available against which the deductible temporary differences, and the carry forward of unused tax credits and unused tax losses can be utilised except when the deferred tax asset relating to the deductible temporary difference arises from the initial recognition of an asset or liability in a transaction that is not a business combination and, at the time of the transaction, affects neither the accounting profit nor taxable profit or loss.

 

The carrying amount of deferred tax assets is reviewed at each reporting date and reduced to the extent that it is no longer probable that sufficient taxable profit will be available to allow all or part of the deferred tax asset to be utilised. Unrecognised deferred tax assets are reassessed at each reporting date and are recognised to the extent that it has become probable that future taxable profits will allow the deferred tax asset to be recovered.

 

Finance costs

Finance costs comprise interest payable on loans from directors and third parties and are recognised on an accruals basis.

 

Share-based payments

The group issues equity-settled share-based payments to certain employees. Equity-settled share-based payments are measured at fair value (excluding the effect of non-market-based vesting conditions) at the date of grant. The fair value determined at the grant date of the equity-settled share-based payments is expensed on a straight-line basis over the vesting period, based on the group's estimate of shares that will eventually vest and adjusted for the effect of non-market-based vesting conditions

 

Fair value is measured by use of the Black Scholes Model. The expected life used in the model has been adjusted, based on management's best estimate, for the effects of non-transferability, exercise restrictions, and behavioural considerations. 

 

Pension contributions

The company operates a defined contribution scheme for its employees.  Contributions are charged to the Statement of Comprehensive Income in the year they are payable. The assets of the scheme are held separately from those of the group.

 

Financial instruments

Financial assets and financial liabilities are recognised when the Group becomes a party to the contractual provisions of the financial instrument.

 

Financial assets are derecognised when the contractual rights to the cash flows from the financial asset expire, or when the financial asset and substantially all the risks and rewards are transferred.

 

A financial liability is derecognised when it is extinguished, discharged, cancelled or expires.

 

Government grants

Government grants are recognised where there is reasonable assurance that the grant will be received and all attached conditions will be complied with. When the grant relates to an expense item, it is recognised as income on a systematic basis over the periods that the costs, which it is intended to compensate, are expensed. The other income included in the Consolidated Statement of Profit or Loss and Other Comprehensive Income relates entirely to government support through the furlough scheme.

 

Where the grant relates to an asset, it is recognised as income in equal amounts over the expected useful life of the related asset.

 

Use of assumptions and estimates

The Group makes judgements, estimates and assumptions that effect the application of policies and reported amounts of assets and liabilities, income and expenses. The resulting accounting estimates calculated using these judgements and assumptions will, by definition, seldom equal the related actual results but are based on historical experience and expectations of future events. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision effects only that period, or in the period of revision and future periods if the revision effects both current and future periods.

 

The judgements and key sources of estimation uncertainty that have a significant effect on the amounts recognised in the financial statements are discussed below.

 

Useful economic lives of intangible assets

Intangible assets are amortised over their useful lives. Useful lives are based on management's estimates, which are periodically reviewed for continued appropriateness. Changes to estimates can result in variations in the carrying values and amounts charged to the statement of comprehensive income in specific periods.

 

Change in accounting policies

The following new standards and amendments to standards are mandatory for the first time for the financial year beginning 1st January 2023.

 

(a) New and amended standards adopted by the Company:

 

There are a number of new standards which have had a material impact in the annual financial statements for the year ended 31 December 2023. These include:

·      Amendments to IAS 1 and IFRS Practice Statement 2 - Disclosure of Accounting Policies

·      Amendments to IAS 12 - Deferred Tax related to Assets and Liabilities arising from a Single Transaction

·      Amendments to IAS 8 - Definition of Accounting Estimates

 

(b) New standards, interpretations, and amendments not yet effective:

 

There are a number of standards, amendments to standards, and interpretations which have been issued by the IASB that are effective in future accounting periods that the Group has decided not to adopt early.

 

These include:

·      Classification of Liabilities as Current or Noncurrent and Non-current Liabilities with Covenants - Amendments to IAS 1

·      Lease Liability in a Sale and Leaseback - Amendments to IFRS 16

·      Disclosures: Supplier Finance Arrangements - Amendments to IAS 7 and IFRS 7

 

 

4. Segmental reporting

 

The chief operating decision maker ("CODM") for the purpose of IFRS 8 is the Board. Segments are determined by reference to the internal reports reviewed by the Board. The group's operations relate to the provision of technology solutions to help clients drive revenues and profit.

 

The Group measures the performance of its operating segments through a measure of segment profit or loss which is referred to as EBITDA. This measure is reported to the CODM for the purposes of resource allocation and assessment of performance. The measure is the same as reported in the historic financial information.

 

Information about geographic location by key segments


Year ended 31 December 2023


UK

Portugal

Total


£'000

£'000

£'000

Revenue

11,650

4,480

16,130

Non-current assets

10,608

2,094

12,702





 


Year ended 31 December 2022


UK

Portugal

Total


£'000

£'000

£'000

Revenue

9,191

4,843

14,034

Non-current assets

9,614

1,783

11,397

 

Information about major customers

Transactions with a single customer exceeding 10% of total revenue amounted to £5,381K in the year (2022: £2,656K) and related to 2 customers (2022: 1).

 

5.  Revenue 

 

The analysis of the Group's revenue by geographical destination is set out below.



2023

2022



£'000

£'000





United Kingdom


11,179

8,670

Europe


385

456

Rest of World


4,566

4,908







16,130

14,034

 

A breakdown of revenue by the two revenue streams as detailed in accounting policies is shown below:


2023

2022


£'000

£'000





Recurring revenue 


12,732

11,824

One off revenue


3,398

2,210







16,130

14,034

 

Revenue is either recognised at a point in time or over the period of the contract in line with the accounting policy (note 2).

The following table provides information on contract assets and contract liabilities from contracts with customers:


2023

2022


£'000

£'000




Contract assets

287

90

Contract liabilities

3,031

2,605

 

Contract assets ("accrued income") are recognised where there are excess of revenues earned over billings. Contracts are classified assets when only the act of invoice is pending, there is an unconditional right to receive cash and only the passage of time is required as per contractual terms.

Contract liabilities ("deferred income") are recognised when there are billings in excess of revenues. Contracts are classified as liabilities when there is      an obligation to transfer goods or services to a customer for which the Group has received consideration from the customer (or the payment is due) but the transfer has not yet completed. These arise based on the billing cycle of the Group's revenues and all are expected to be reversed in under one year.

 

6.         Loss on operating activities before taxation

 

Loss on ordinary activities before taxation is stated after charging:


2023

2022


£'000

£'000




Share based payments

-

58

Deprecation of owned tangible fixed assets

49

42

Depreciation of leased assets

545

452

Amortisation of intangible assets

1,146

889

Auditors' remuneration (see note 7)

70

60

 

 

7.         Auditors' remuneration

 

            The analysis of auditors' remuneration is as follows:



 2023
£'000

 2022
£'000

Fees payable to the company's auditors for the audit of the company's annual accounts


37

31

Fees payable to the company's auditors and their associates for other services to the group




•     The audit of the company's subsidiaries pursuant to legislation


28

24

•     Tax compliance services


5

5

Total other services


70

60

 

8.         Employee information

 

Their aggregate emoluments were:




 2023
£'000

 2022
£'000






Wages and salaries



8,701

7,965

Social security costs



1,263

1,194

Other pension costs



307

270

Other benefits



338

370











10,609

9,799

 

The average monthly number of employees (including directors) during the year for the group was as follows:




2023
No.

2022
No.






Selling and administration



29

27

Technical



144

147











173

174

 

9.         Directors' emoluments

 

 

 



 2023
£'000

 2022
£'000






Aggregate emoluments



970

925

Pension contributions (money purchase schemes)



39

38










1,009

963

 

 

Directors' emoluments disclosed above include the following payments to the highest director:

 

 

 



 2023
£'000

 2022
£'000






Aggregate emoluments



347

332

Pension contributions (money purchase schemes)



17

16





364

348

 

 




2023
No.

2022
No.






Number of directors to whom relevant benefits are accruing under:



Money purchase schemes



2

2

 

The above is equivalent to total key management personnel compensation. There were no other key management personnel other than the Directors.

Further details of Directors remuneration can be found in the remuneration report on pages 23 to 24.

Share based compensation

The Group operates an equity-settled share based compensation plan for Directors and executives. In accordance with IFRS 1, the Group has elected to implement the measurement requirements of IFRS 2 in respect of only those equity-settled share options that were granted after 7 November 2002 and that had not vested as at 1 January 2005. The fair value of the employee services received in exchange for the grant of options is recognised as an expense over the vesting period. The total amount to be expensed over the vesting period is determined by reference to the fair value of the options granted at the grant date.

At each year end date, the Group revises its estimate of the number of options that are expected to vest. It recognises the impact of the revision of original estimates, if any, in the Statement of Consolidated Income, and a corresponding adjustment to equity over the remaining vesting period. When share options are cancelled the Group accounts for the cancellation as an acceleration of vesting and therefore recognises immediately the amount that otherwise would have been recognised for services received over the remainder of the vesting period. The proceeds received net of any directly attributable transaction costs are credited to share capital (nominal value) and share premium when the options are exercised. The fair value of share options has been assessed using the Black Scholes Model.

 

No share options were granted to Directors in the period (2022 - Nil).

Included on the face of the Statement of Comprehensive Income, is a total charge for share based payments of £Nil (2022: £58,341) which arises wholly from transactions accounted for as equity settled share based payments.

 

10.        Taxation

(a)  Taxation charge:

 



 2023
£'000

2022
£'000





Total current income tax credit charged in the income statement




Research and development tax credit

Portugal corporate tax


(400)

19

(600)

22

Adjustment in respect of prior years


40

(40)

Total current income tax


(341)

(618)

Deferred tax expense




Current year


136

29



136

29

Total income tax


(205)

(589)

 

(b)  Taxation reconciliation:

The current income tax credit for the year is explained below:



2023
£'000

2022
£'000





Loss before tax


(1,097)

(1,275)





Loss at the standard UK income tax rate of 19% (2022: 19%)


(208)

(242)





Effects of:




Expenses not deductible for tax purposes


153

130

Capital allowances in excess of depreciation


44

(123)

Tax losses utilised as part of research and development tax credit


(400)

(600)

Unrelieved tax losses and other deductions arising in the year


98

383

B/fwd losses relieved


(96)

(36)

Adjustment in respect of earlier year


40

(40)

Difference in overseas tax rates and temporary GAAP differences


28

(90)

Recognition of deferred tax asset in respect of losses


-

(15)

Other deferred tax timing differences


136

44





Total income tax credited in the income statement


(205)

(589)

 

(c)  Deferred tax

Deferred tax balances consist of the following timing differences

Group:


 

Group

Company


 

2023

2022

2023

2022


 

£'000

£'000

£'000

£'000

Deferred tax asset






Acceleration capital allowances - UK


(749)

(603)

-

-

Tax losses available for carry forward - UK


760

760

-

-

Other timing differences - UK


2

7

-

-

At 31 December


13

164

-

-

 

The Group has not recognised all deferred tax assets in respect of tax losses due to timing uncertainty regarding the recoverability against future profits. If all tax losses were recognised the deferred tax asset would increase as below in each year.


 

Group

Company


 

2023

2022

2023

2022


 

£'000

£'000

£'000

£'000

Deferred tax asset






Acceleration capital allowances - UK


(749)

(603)

-

-

Tax losses available for carry forward - UK


2,063

2,049

-

-

Other timing differences - UK


2

7

-

-

At 31 December


1,316

1,453

-

-

Increase in deferred tax asset if all losses recognised


1,303

1,289

-

-

 



Group

Company



2023

2022

2023

2022



£'000

£'000

£'000

£'000

Deferred tax liability






Acceleration capital allowances - UK


(71)

(123)

(71)

(123)

Tax losses available for carry forward - UK


-

39

-

39

Other timing differences - UK


(1)

-

(1)

-

Acceleration capital allowances - Portugal


(382)

(361)

-

-

Arising on business combinations - UK


(161)

(185)

-

-

At 31 December


(615)

(630)

(72)

(84)

 

The movement in deferred tax assets during the period are:

Group


Accelerated capital allowances on PPE- UK

£'000

Accelerated capital allowances  Development costs- UK

£'000

Tax losses available for carry forward- UK

£'000

Other timing differences- UK

£'000

Total

£'000

Deferred tax assets






At 31 December 2021

(46)

(420)

528

3

65

 Charged to profit and loss account

(86)

(174)

271

4

15

Transfer to liability

123

-

(39)

-

84

At 31 December 2022

(9)

(594)

760

7

164

 Charged to profit and loss account

(8)

(138)

-

(5)

(151)

At 31 December 2023

(17)

(732)

760

2

13

 

The movement in deferred tax liabilities during the period are:

Group


Accelerated capital allowances on PPE- UK

£'000

Tax losses available for carry forward- UK

£'000

Accelerated capital allowances on Development costs- Portugal

£'000

 

Other Timing differences

            £'000

Timing differences on acquired intangible assets- UK

£'000

Total

£'000

Deferred tax liabilities







At 31 December 2021

-

-

(292)

-

(210)

(502)

 Charged to profit and loss account

-

-

(69)

 

-

25

 

(44)

Transfer from asset

(123)

39

-

-

-

(84)

At 31 December 2022

(123)

39

(361)

-

(185)

(630)

Charged to profit and loss account

52

(39)

(21)

 

(1)

24

 

15

At 31 December 2023

(71)

-

(382)

(1)

(161)

(615)

 

Company


Accelerated capital allowances on PPE- UK

£'000

Tax losses available
for carry
forward- UK

£'000

 

 

Other Timing differences

            £'000

Total

£'000

Deferred tax liabilities





At 31 December 2021

-

-

-

-

Transferred from asset

(123)

39

-

(84)

At 31 December 2022

(123)

39

-

(84)

Charged to profit and loss account

52

(39)

(1)

12

At 31 December 2023

(71)

-

(1)

(72)

 

11.        Loss per share

Basic and diluted loss per share is calculated by dividing the profit attributable to owners of the parent by the weighted average number of ordinary shares in issue during the period. For the avoidance of doubt the deferred shares have been excluded as they have no rights to profits or capital. Additionally, the Company's ordinary shares were subject to a share consolidation where 5 ordinary shares were converted into 1 ordinary share. The comparative period weighted average number of shares has been adjusted for this to aid comparison. The Company's share options have a dilutive effect over the two year period.

 


2023

2022


£'000

£'000

Loss after tax for the year

(892)

(686)

Share option charge

-

58

Adjusted loss after tax for the year

(892)

(628)

Weighted average number of shares:



Basic - 000

31,211

31,211

Potentially dilutive share options - 000

3,657

3,657

Diluted average number of shares - 000

34,868

34,868




Loss per share:



Basic - pence on continuing operations

(2.86)

(2.20)

Diluted - pence on continuing operations

(2.86)

(2.20)

Adjusted earnings/(loss) - Basic - pence on continuing operations

(2.86)

(2.01)

Adjusted Diluted - pence on continuing operations

(2.86)

(2.01)

 

 

12.        Intangible assets

Group


Purchase of software

 

Development cost

 

Goodwill

Acquired intellectual property rights

Customer contracts

 

Total


£'000

£'000

£'000

£'000

£'000

£'000

Cost














At 1 January 2023

-

15,684

8,712

300

1,000

25,696

Foreign exchange differences

-

(66)

-

-

-

(66)

Additions

350

1,870

-

-

-

2,220

At 31 December 2023

350

17,488

8,712

300

1,000

27,850








Amortisation














At 1 January 2023

-

10,543

4,759

75

250

15,627

Foreign exchange differences

-

(32)

-

-

-

(32)

Charge for the period

-

1,016

-

30

100

1,146

At 31 December 2023

-

11,527

4,759

105

350

16,741

Net book value







At 31 December 2023

350

5,961

3,953

195

650

11,109

At 31 December 2022

-

5,141

3,953

225

750

10,069

 

Goodwill arising prior to 1 January 2020 relates to acquisition prior to the date of transition to IFRS of 1 January 2015 and therefore the exemption for business combinations completed before that date has been applied and the amounts not restated.

The Board consider that there is only one Cash Generating Unit.  In accordance with the accounting policy, goodwill is tested annually for impairment, Management have used a fair value less cost of sales methodology supported by offers for the Group and consider that the value supports the carrying value of goodwill at each period end.

 

Company

             

Purchase of software

Development
costs

 

Total


£'000

£'000

£'000

Cost








At 1 January 2023

-

13

13

Additions

350

-

350

At 31 December 2023

350

13

363





Amortisation








At 1 January 2023

-

13

13

Charge for the period

-

-

-

At 31 December 2023

-

13

13

 




Net book value




At 31 December 2023

350

-

350

At 31 December 2022

-

-

-

 

13.        Plant and equipment

Group

 




Fixtures and equipment

 

Total




£'000

£'000

Cost










At 1 January 2023



1,862

1,862

Foreign exchange differences



(2)

(2)

Additions



77

77






At 31 December 2023



1,937

1,937






Depreciation









At 1 January 2023



1,141

1,141

Foreign exchange differences



(2)

(2)

Charge for the period owned assets



49

49

Charge for the period leased assets



273

273

At 31 December 2023



1,461

1,461






Net book value





At 31 December 2023



476

476

At 31 December 2022



721

721

 

Company




Fixtures and equipment

Total




£'000

£'000

Cost










At 1 January 2023



837

837

Additions



-

-






At 31 December 2023



837

837






Depreciation










At 1 January 2023



190

190

Charge for the period



273

273

At 31 December 2023



463

463






Net book value





At 31 December 2023



374

374

At 31 December 2022



647

647

 

14.        Investments

The principal subsidiaries of itim Group plc, all of which have been included in these consolidated financial statements, are as follows:

 

Company


Shares in group undertaking

Other investments

Total

£'000

£'000

£'000

Cost





At 1 January 2023 and at 31 December 2023

8,005

46

8,051









Provision for impairment




 




At 1 January 2023 and at 31 December 2023

2,934

46

2,980





Net book value




At 31 December 2023

5,071

-

5,071

At 31 December 2022

5,071

-

5,071

 

The company holds more than 20% of the share capital of the following companies:

 

Subsidiary undertakings

Country of
Incorporation

Percentage holding

Class of share

Principal activity

Profit/
(loss)

£'000

Net assets/
(liabilities)

£'000

ITIM Limited

England and Wales

100%

Ordinary 'A'
Ordinary
Deferred

Software consultancy and supply

(1,793)

(10,506)

EDI Plus Limited

England and

Wales

100%

Ordinary

Data exchange services

167

1,179

Profimetrics Software Solutions S.A

Portugal

100%

Ordinary
Preferred

Development and distribution of software

(86)

2,060

                                                              

The registered address of ITIM limited and EDI Plus Limited are same as ITIM Group Plc.

The registered address of Profimetrics Software Solutions S.A. is R. Lionesa 446, Edifício C Loja L, 4465-671 Leça do Balio, Portugal.

 

15. Trade and other receivables

 

 

 

Group

Company

 


2023

£'000

2022

£'000

2023

£'000

2022

£'000







Trade receivables


4,075

2,925

-

-

Corporation tax


502

648

-

-

Amounts owed by group undertakings due within one year


-

-

13,537

11,485

Amounts owed by group undertakings due in greater than one year


-

-

1,842

1,881

Other receivables due within one year


12

134

-

-

Other receivables due in greater than one year


46

-

46

-

Loan receivables


-

350

-

350

Prepayments and accrued income


750

546

66

58









5,385

4,603

15,491

13,774

 

16.        Trade and other payables

 

 

 Group

Company


2023

£'000

2022

£'000

2023

£'000

2022

£'000






Trade payables

1,189

818

199

32

Corporation tax

-

23

-

-

Amounts owed by group undertakings due within one year

-

-

101

-

Other taxation and social security

870

796

4

68

Other payables

232

225

195

188

Loans and borrowings (see note 19 below)

302

318

302

318

Accruals

774

991

26

41

Deferred income

3,031

2,605

-

-







6,398

5,776

827

647

 

17.        Trade and other payables due in more than one year

 

 

Group

Company


2023

£'000

2022

£'000

2023

£'000

2022

£'000






Other payables

347

540

347

540







347

540

347

540

 

Net obligations under finance leases are secured by fixed charges on the assets concerned.

 

18.        Loans and borrowings

 

 

Group

Company


2023

£'000

2022

£'000

2023

£'000

2022

£'000






Accrued interest

302

318

302

318







302

318

302

318

 

Analysis of maturity of loans and borrowings

 

 

Group

Company

 

2023

£'000

2022

£'000

2023

£'000

2022

£'000






Amounts payable





Within one year

302

318

302

318







302

318

302

318

 

Accrued interest relates to interest due on fully repaid Director loans.

 

19.  Leases

 

The Group leases five units within properties from which it operates and also leases computer equipment for the hosting centre. Lease payments are fixed throughout the contract period.

Group


Right-of-use - Property

£'000

Right-of-use - Equipment

£'000

 

Total
£'000

Cost








At 1 January 2023

1,197

234

1,431

Foreign exchange differences

(6)

-

(6)

Additions

898

-

898

Disposals

(947)

(31)

(978)

At 31 December 2023

1,142

203

1,345





Depreciation








At 1 January 2023

853

136

989

Foreign exchange differences

5

-

5

Charge for the year

231

40

271

Disposals

(947)

(31)

(978)

At 31 December 2023

142

145

287





Net book value




At 31 December 2023

58

1,058

At 31 December 2022

344

98

442

Lease liabilities:

 



2023

   £'000

2022

   £'000









At 1 January


498

724

Foreign exchange movement


(10)

4

Interest expense


23

30

Lease payments


(321)

(331)

Additions


892

71

At 31 December


1,082

498

Amounts payable are as follows:

 



2023

   £'000

2022

   £'000





Due within 1 year


287

297

Due 2-5 years


785

171

Due over 5 years


10

30

Total


1,082

498

 

The Group's right of use assets consist of the Company's premises, data centres' and sundry office equipment.  The expiry of the leases varies between 1 and 6 years.

 

Company


Right-of-use -
Property

£'000

 

Total
£'000

Cost






At 1 January 2023

-

-

Additions

551

551

At 31 December 2023

551

551




Depreciation






At 1 January 2023

-

-

Charge for the year

-

-

At 31 December 2023

-

-




Net book value



At 31 December 2023

551

551

At 31 December 2022

-

-

 

Lease liabilities:

 



2023

   £'000

2022

   £'000









At 1 January


-

-

Additions


545

-



            

            

At 31 December


545

-

 

Amounts payable are as follows:

 



2023

   £'000

2022

   £'000





Due within 1 year


131

-

Due 2-5 years


414

-

Due over 5 years


-

-





Total


545

-

 

20. Financial instruments

Financial risk factors

The Group's financial assets comprise cash and cash equivalents, trade receivables and accrued income. These are all measured at amortised cost. The financial liabilities comprise loans and borrowings, trade payables and accruals, lease liabilities and deferred consideration payable for acquisitions of subsidiaries.  These are measured at amortised cost.

The majority of the financial instruments arise directly from the operations with the exception of loans and borrowings and lease liabilities which have been used to finance the operations.

Fair values of financial instruments

For the following financial assets and liabilities: trade and other payables, trade and other receivables and cash at bank and in hand, the carrying amount approximates the fair value of the instrument due to the short-term nature of the instrument. The Directors consider that there is no material difference between book value and fair value for any of the financial instruments held.

Financial risk management

The Group's activities expose the Group to a number of risks including capital management risk, interest rate risk, foreign exchange risk, credit risk and liquidity risk.

It is the Group's policy that no trading in financial instruments should be undertaken.

There have been no substantive changes in the Group's exposure to financial instrument risks, its objectives, policies and processes for managing those risks or the methods used to measure them from previous periods unless otherwise stated in this note.

The Board has overall responsibility for the determination of the Group's risk management objectives and policies and, whilst retaining ultimate responsibility for them, it has delegated the authority for designing and operating processes that ensure the effective implementation of the objectives and policies to the Group's finance function. The Board receives monthly reports from the Finance Department through which it reviews the effectiveness of the processes put in place and the appropriateness of the objectives and policies it sets.

The overall objective of the Board is to set policies that seek to reduce risk as far as possible without unduly affecting the Group's competitiveness and flexibility. Further details regarding these policies are set out below:

Interest rate risk

There is no interest rate risk as there are no borrowings in the Group.

Credit risk

Credit risk is the risk of financial loss to the Group if a customer or counterparty to a financial instrument fails to meet its contractual obligations.

The Group's largest financial assets are the cash balances held in banks and it is exposed to credit risk on those balances. It is the Group's policy only to make deposits with banks with an acceptable credit rating.

The Group is mainly exposed to credit risk from credit sales. It is Group policy, implemented locally, to assess the credit risk of new customers before entering contracts. Such credit ratings are taken into account by local business practices. An ageing analysis of trade receivables is detailed below:

 

 

2023

Total

£'000

Current

£'000

30-60 days

£'000

> 60 days

£'000






Trade and other receivables

4,075

1,898

1,629

548

Contract assets

287

287

-

-







4,362

2,185

1,629

548






2022

Total

£'000

Current

£'000

30-60 days

£'000

> 60 days

£'000






Trade and other receivables

2,925

1,299

967

659

Contract assets

90

90

-

-







3,015

1,389

967

659

 

Trade receivables are recognised initially at the transaction price. They are subsequently measured less any provision for impairment in relation to expected credit losses. At each reporting date the Group assesses the expected credit losses and changes in credit risk since initial recognition of the receivable and a provision for impairment is recognised when considered necessary. The Group considers the ageing to be reasonable and has no history of significant bad debts. No provisions have been made in in these financial statements. The Board do not consider the credit risk to be significant for the financial assets currently held.

Foreign exchange risk

Foreign exchange risk arises when individual Group entities enter into transactions denominated in a currency other than their functional currency. The Group's policy is, where possible, to allow Group entities to settle liabilities denominated in their functional (currency). Where Group entities have liabilities denominated in a currency other than their functional currency (and have insufficient reserves of that currency to settle them), cash already denominated in that currency will, where possible, be transferred from elsewhere within the Group.

The Group's main exposure to foreign currency risk is on the trade receivables in the Portuguese subsidiary which are not held in Euros. The Directors have considered the balances at year end and based on the level of foreign currency balances and the expected timing of settlement of those amounts that the foreign exchange risk is not material.

Liquidity risk

Liquidity risk is the risk that ITIM Group may encounter difficulty in meeting its obligations associated with the financial liabilities that are settled by delivering cash or other financial assets.  The Group actively maintains a mixture of long-term and short-term debt finance that is designed to ensure the Group has sufficient available funds for operations and planned expansions.

The Group would normally expect that sufficient cash is generated in the operating cycle to meet the contractual cash flows through effective cash management. The maturity analysis of the financial liabilities are included below:

 

 

As at 31 December 2023

Carrying amount

£'000

1 year or less

£'000

1<2 years

 

£'000

2-5years

 

£'000

5 years

 

£'000

Trade and other payables

2,541

2,194

347

-

-

Right of use liability

1,082

287

271

514

10

Other loans and borrowings

302

302

-

-

-


3,925

2,783

618

514

10

 

 

As at 31 December 2022

Carrying amount

£'000

1 year or less

£'000

1<2 years

 

£'000

2-5years

 

£'000

5 years

 

£'000

Trade and other payables

2,574

2,034

540

-

-

Right of use liability

498

297

85

86

30

Other loans and borrowings

318

318

-

-

-


3,390

2,649

625

86

30

Capital management risk

The Group's main objective when managing capital is to protect returns to shareholders by ensuring the Group will continue to trade for the foreseeable future. The Group also aims to optimise its capital structure of debt and equity so as to minimise its cost of capital. The Group in particular reviews its levels of borrowing and the repayment dates, setting these out against forecast cash flows and reviewing the level of available funds.

 

21.        Share capital



2023

£'000

2022

£'000





Authorised:








37,949,651 Ordinary shares of 5p each


1,898

1,898







1,898

1,898

 

 

 


2023

£'000

2022

£'000

Allotted, called up and fully paid:




31,210,607 Ordinary shares of 5p each


1,561

1,561







1,561

           1,561

 

A summary of the rights of the different classes of share is given below:

Voting

All Ordinary shares are entitled to one vote each. The holders of deferred shares are not entitled to receive notice of, to attend, to speak or to vote at any general meeting of the Company.

Dividends         

The profits of the Company available for distribution shall be used to pay dividends to the holders of Ordinary Shares a dividend equivalent to such amounts as the Directors may determine and as is approved by the Ordinary Shareholders in general meeting.

 

22.        Reserves

Share premium

This reserve records the amount above the nominal value received for shares sold, less transaction costs.

Share options reserve

The share options reserves represent the fair value of equity-settled share options granted using the Black Scholes model.

Capital redemption reserve

This reserve arises on the purchase of the company's own shares.

Foreign exchange reserve

This reserve includes any exchange differences arising on the retranslation of foreign subsidiaries on consolidation.

Retained earnings

This balance represents the cumulative profit and loss made by the Group net of distributions to owners.

 

23.        Share-based payments

Share options

The Company has a share option scheme for certain employees of the Group. Options are granted with a fixed exercise price. The vesting period varies from vesting immediately to vesting over 2 years from the date of grant. If the options remain unexercised after a period of ten years from the date of grant the options expire. Options are forfeited if the employee leaves the Group before the options vest.

Details of equity settled share options outstanding during the year are as follows:

Year ended 31 December 2023

Grant date

Outstanding at 1 January 2023

Granted

Exercised

Lapsed

Outstanding at 31 December 2023

Exercise period

Exercise price









14/04/2015

150,000

-

-

-

150,000

10 years

7.975p

10/04/2017

2,615,000

-

-

-

2,615,000

10 years

15.000p

31/03/2021

400,000

-

-

-

400,000

10 years

70.000p

19/04/2021

492,041

-

-

-

492,041

10 years

70.000p


3,657,041

-

-

-

3,657,041



 

Year ended 31 December 2022

Grant date

Outstanding at 1 January 2022

Granted

Exercised

Lapsed

Outstanding at 31 December 2022

Exercise period

Exercise price









14/04/2015

150,000

-

-

-

150,000

10 years

7.975p

10/04/2017

2,615,000

-

-

-

2,615,000

10 years

15.000p

31/03/2021

400,000

-

-

-

400,000

10 years

70.000p

19/04/2021

492,041

-

-

-

492,041

10 years

70.000p


3,657,041

-

-

-

3,657,041



 

Details of the share options and weighted average exercise price (WAEP) during the years are as follows:


31 December 2023

31 December 2022


Number

WAEP

Number

WAEP






Outstanding at the beginning of the year

3,657,041

28.13p

3,657,041

28.13p

Share consolidation

-

-

-

-

Granted during the year

-

-

-

-

Exercised during the year


-


-

Lapsed during the year

-

-

-

-

Forfeited during the year

-

-

-

-


3,657,041

28.13p

3,657,041

28.13p

The weighted average contractual life of share options outstanding as at 31 December 2023 was 4 years (31 December 2022: 5 years).

 

ITIM recognises equity settled share-based payment expenses based on the fair value determined by the Black Scholes model. The model is internationally recognised as being appropriate to value employee share options schemes. The inputs into the option issues were as follows:

 



Year ended
31 December 2023 

Year ended
31 December 2022 

Expected life


10 years

10 years

Risk free rate


0.5%

0.5%

Risk-free rate

The risk-free interest rate is based on the Bank of England's base rate.

Volatility

The measure of volatility is based management's estimate after considering the historical volatility of guideline companies operating within the same industry as ITIM Group, over a 10-year time period.

 

24.        Company statement of changes in equity

 

 

 

Share capital

£'000

Share premium

£'000

Share options

reserve

£'000

Capital

Redemption

Reserve

£'000

Retained losses

£'000

 

 

Total

£'000








At 1 January 2022

1,561

7,398

455

1,103

8,095

18,612

Total comprehensive income for the year

-

-

-

-

592

592

Share option charge

-

-

58

-

                     -

58








At 1 January 2023

1,561

7,398

513

1,103

8,687

19,262

Total comprehensive income for the year

-

-

-

-

924

924








At 31 December 2023

1,561

7,398

513

1,103

9,611

20,186

           

The profit for the year dealt with in the financial statements of the parent company is shown above. As permitted by section 408 of the Companies Act 2006, no separate income statement is presented in respect of the parent company.

25. Pension commitments

The group makes contributions to individual pension schemes (money purchase).  The amount paid during the year was £307,243 (2022: £269,779). Outstanding contributions at the balance sheet date amounted to £37,846 (2022: £36,042).

 

26. Contingent liabilities

itim Group plc and its subsidiary undertakings have given cross guarantees and been granted rights to set-off in respect of group undertaking overdrafts and loans. 

 

27. Related party transactions

The Group has taken advantage of the exemption available under IAS 2 Related Party Disclosures not to disclose details of transactions between Group undertakings which are eliminated on consolidation.

 

28. Supporting statement for cash flows

 

Year ended 31 December 2023

 

Brought forward

£'000

Cash
Flow

£'000

Non
Cash

£'000

Carried forward

£'000

Loans and borrowings

     (318)

16

-

     (302)

Leases

(498)

321

(905)

(1,082)

 

 

Year ended 31 December 2022

 

Brought forward

£'000

Cash
Flow

£'000

Non
Cash

£'000

Carried forward

£'000

Loans and borrowings

     (318)

-

-

     (318)

Leases

(724)

331

(105)

(498)

 

29. Controlling party

            There is no single ultimate controlling party.



 

Notice of Annual General Meeting

NOTICE IS HEREBY GIVEN that the annual general meeting of itim Group plc (the "Company") will be held at the offices of the Company, 2nd Floor, Atlas House, 173 Victoria Street, London SW1E 5NA on 14th June 2024 at 10.30 a.m. to consider and, if thought fit, to pass the following resolutions, of which resolutions 1 to 10 (inclusive) will be proposed as ordinary resolutions and resolutions 11 and 12 will be proposed as special resolutions. Resolutions 11 to 12 (inclusive) are items of special business.

 

ORDINARY RESOLUTIONS

1.  

To receive the Company's annual accounts for the financial year ended 31 December 2023 together with the directors' report, the directors' remuneration report and the auditors' report on those accounts.

 

2.  

To re-appoint RPG Crouch Chapman LLP as auditors of the Company to hold office until the conclusion of the next annual general meeting of the Company to be held in 2025 and to authorise the directors to fix their remuneration.

 

3.  

To re-elect Sandra Ribeiro as a director.

 

4.  

To re-elect Michael Jackson as a director.

 

5.  

To re-elect Justin King as a director.

 

6.  

To re-elect Lee Williams as a director.

 

7.  

To re-elect Ian Hayes as a director.

 

8.  

To re-elect Mahmood Ali Athar as a director.

 

9.  

To re-elect Robert Frosell as a director.

 

10. 

That, in substitution for any equivalent existing and unexercised authorities and powers, the directors of the Company be and they are hereby generally and unconditionally authorised for the purpose of section 551 of the Companies Act 2006 (the "Act") to exercise all or any of the powers of the Company to allot shares of the Company or to grant rights to subscribe for, or to convert any security into, shares of the Company up to an aggregate nominal value of £520,177 to such persons at such times and generally on such terms and conditions as the directors may determine (subject always to the articles of association of the Company), provided that this authority shall, unless previously renewed, varied or revoked by the Company in general meeting, expire at the conclusion of the next annual general meeting of the Company to be held in 2025 or, if earlier, 14 September 2025, save that the directors of the Company may, before the expiry of such period, make an offer or agreement which would or might require such securities to be allotted after the expiry of such period and the directors of the Company may allot such securities in pursuance of such offer or agreement as if the authority conferred hereby had not expired.

 

SPECIAL RESOLUTIONS

1.  

That, subject to and conditional upon the passing of resolution 10 and in substitution for any equivalent existing and unexercised authorities and powers, the directors of the Company be and are hereby empowered pursuant to sections 570 and 573 of the Act to allot equity securities (as defined in section 560(1) of the Act) for cash pursuant to the authority conferred upon them by resolution 10 and/or where the allotment constitutes an allotment of equity securities by virtue of section 560(3) of the Act, as if section 561 of the Act did not apply to any such allotment provided that this authority and power shall be limited to the allotment of equity securities up to an aggregate nominal amount of £78,027 (representing approximately 5 per cent. of the current issued share capital of the Company) provided that this authority shall, unless previously renewed, varied or revoked by the Company in general meeting, expire at the conclusion of the next annual general meeting of the Company to be held in 2025 or, if earlier, 14 September 2025, save that the directors of the Company may, before the expiry of such period, make an offer or agreement which would or might require such securities to be allotted after the expiry of such period and the directors of the Company may allot such securities in pursuance of such offer or agreement as if the authority conferred hereby had not expired.



2.  

That the Company be and is hereby generally and unconditionally authorised for the purpose of section 701 of the Act to make market purchases (within the meaning of section 693(4) of the Act) of ordinary shares in the capital of the Company ("Ordinary Shares") provided that:



a.  

the maximum aggregate number of Ordinary Shares which may be purchased is 3,121,060 (representing approximately 10 per cent. of the Company's existing issued share capital);



b.  

the minimum price (exclusive of expenses) which may be paid for each Ordinary Share is £0.05 (being its nominal value);



c.  

the maximum price (exclusive of expenses) which may be paid for each Ordinary Share is the higher of: (i) an amount equal to 105 per cent. of the average of the middle market quotations for an Ordinary Share as derived from the Daily Official List of the London Stock Exchange plc for the 5 business days immediately preceding the day on which the Ordinary Share in question is purchased; and (ii) the value of an Ordinary Share calculated on the basis of the higher of the price quoted for the last independent trade of an Ordinary Share and the highest current independent bid for an Ordinary Share as derived from the London Stock Exchange Trading System;



d.  

unless previously renewed, revoked or varied, the authority hereby conferred shall expire at the conclusion of the next annual general meeting of the Company to be held in 2025 or, if earlier, 14 September 2025; and



e.  

the Company may make a contract or contracts to purchase Ordinary Shares under the authority hereby conferred prior to the expiry of such authority which contract or contracts will or may be executed wholly or partly after the expiry of such authority, and may make a purchase of Ordinary Shares in pursuance

 

BY ORDER OF THE BOARD

Ian Hayes

Secretary

Date: 10th May 2024

Registered office: 2nd Floor Atlas House, 173 Victoria Street, London, SW1E 5NH



 

NOTES:

1. 

Pursuant to the Company's Articles of Association, a member of the Company entitled to attend and vote at the meeting convened by this notice is entitled to appoint one or more proxies to exercise any of his rights to attend, speak and vote at that meeting on his behalf.



2. 

If a member appoints more than one proxy, each proxy must be entitled to exercise the rights attached to different shares. If you submit more than one valid proxy appointment in respect of the same shares, the appointment received last before the latest time for the receipt of proxies will take precedence.



3. 

A proxy may only be appointed using the procedures set out in these notes and the notes to the form of proxy. To validly appoint a proxy, a member must complete, sign and date the enclosed form of proxy and deposit it at the office of the Company's registrars, Neville Registrars, at Neville House, Steelpark Road, Halesowen, West Midlands B62 8HD, by 10.30 a.m. on 12 June 2024 (or, in the event that the meeting is adjourned, not less than 48 hours, excluding non-working days, before the time fixed for the holding of the adjourned meeting). Any power of attorney or any other authority under which the form of proxy is signed (or a duly certified copy of such power or authority) must be enclosed with the form of proxy.



4. 

In order to revoke a proxy appointment, a member must sign and date a notice clearly stating his intention to revoke his proxy appointment and deposit it at the office of the Company's registrars, Neville Registrars, at Neville House, Steelpark Road, Halesowen, West Midlands B62 8HD prior to commencement of the meeting. If the revocation is received after the time specified, the original proxy appointment will remain valid unless the member attends the meeting and votes in person.



5. 

Pursuant to the Articles of Association, any corporation which is a member of the Company may authorise one or more persons (who need not be a member of the Company) to attend, speak and vote at the meeting as the representative of that corporation. A certified copy of the board resolution of the corporation appointing the relevant person as the representative of that corporation in connection with the meeting must be deposited at the office of the Company's registrars, Neville Registrars, at Neville House, Steelpark Road, Halesowen, West Midlands B62 8HD prior to the commencement of the meeting. If the revocation is received after the time specified, the original corporate representative appointment will remain valid unless the member attends the meeting and votes in person.



6. 

In the case of joint holders, where more than one of the joint holders purports to appoint a proxy in respect of the same shares, only the appointment submitted by the most senior holder will be accepted. Seniority is determined by the order in which the names of the joint holders appear in the Company's register of members in respect of the joint holding (the first named being the most senior).



7. 

The right to vote at the meeting shall be determined by reference to the register of members of the Company. Pursuant to Regulation 41 of the Uncertificated Securities Regulations 2001 (as amended), only those persons whose names are entered on the register of members of the Company at 6.00 p.m. on 12 June 2024 (or, in the event of any adjournment, at 6.00 p.m. on the date which is two business days prior to the adjourned meeting) shall be entitled to attend and vote in respect of the number of shares registered in their names at that time. Changes to entries on the register of members after that time shall be disregarded in determining the rights of any person to vote at the meeting.



8. 

CREST members who wish to appoint a proxy or proxies through the CREST electronic proxy appointment service may do so for the meeting and any adjournment(s) thereof by using the procedures described in the CREST Manual (available via www.euroclear.com). CREST personal members or other CREST sponsored members, and those CREST members who have appointed a voting service provider(s), should refer to their CREST sponsor or voting service provider(s), who will be able to take the appropriate action on their behalf.



9. 

In order for a proxy appointment or instruction made by means of the CREST service to be valid, the appropriate CREST message (a "CREST Proxy Instruction") must be properly authenticated in accordance with Euroclear UK & International Limited's ("Euroclear") specifications and must contain the information required for such instructions, as described in the CREST Manual. The message, regardless of whether it constitutes the appointment of a proxy or is an amendment to the instruction given to a previously appointed proxy must, in order to be valid, be transmitted so as to be received by the Company's agent (ID 7RA11) by the latest time for proxy appointments set out in paragraph 3 above. For this purpose, the time of receipt will be taken to be the time (as determined by the timestamp applied to the message by the CREST Applications Host) from which the Company's agent is able to retrieve the message by enquiry to CREST in the manner prescribed by CREST. After this time any change of instructions to proxies appointed through CREST should be communicated to the appointee through other means.



10.  

CREST members and, where applicable, their CREST sponsors or voting service providers should note that Euroclear does not make available special procedures in CREST for any particular messages. Normal system timings and limitations will therefore, apply in relation to the input of CREST Proxy Instructions. It is the responsibility of the CREST member concerned to take (or, if the CREST member is a CREST personal member or sponsored member or has appointed a voting service provider(s), to procure that his CREST sponsor or voting service provider(s) take(s)) such action as shall be necessary to ensure that a message is transmitted by means of the CREST system by any particular time. In this connection, CREST members and, where applicable, their CREST sponsors or voting service providers are referred, in particular, to those sections of the CREST Manual concerning practical limitations of the CREST system and timings. The Company may treat as invalid a CREST Proxy Instruction in the circumstances set out in Regulation 35(5)(a) of the Uncertificated Securities Regulations 2001 (as amended).



11.  

As at 9th May 2024, the latest practicable date prior to the date of this notice, the Company's issued share capital consisted of 31,210,607 ordinary shares of £0.05 each, carrying one vote each and, therefore, the total number of voting rights in the Company as at 9th May 2024 were 31,210,607.



12.  

You may not use any electronic address (within the meaning of section 333(4) of the Companies Act 2006) provided in this notice or in any related documents (including the form of proxy and the annual report and accounts) to communicate with the Company for any purposes other than those expressly stated.



13.  

Your personal data includes all data provided by you, or on your behalf, which related to you as a shareholder, including your name and contact details, the votes you cast and your reference number (as attributed to you by the Company or its registrars). The Company determines the purposes for which, and the manner in which, your personal data is to be processed. The Company and any third party to which it discloses the data (including the Company's registrars) may process your personal data for the purposes of compiling and updating the Company's records, fulfilling its legal obligations and processing the shareholder rights you exercise.

 

EXPLANATORY NOTES:

Resolutions 1 to 10 (inclusive) are proposed as ordinary resolutions. For each of these to be passed, more than half of the votes cast must be in favour of the relevant resolution.

Resolutions 11 and 12 are proposed as special resolutions. For each of these resolutions to be passed, at least three quarters of the votes cast must be in favour of the resolution. An explanation of each of the resolutions is set out below:

Resolution 1 - Annual Report and Accounts

The Directors are required to present to the annual general meeting the audited accounts and the Directors' and Auditors' Reports for the financial year ended 31 December 2023.

Resolution 2 - Auditors

The Company is required to appoint an auditor at every general meeting of the Company at which accounts are presented to shareholders. The appointment of RPG Crouch Chapman LLP. Accordingly, this resolution proposes the re-appointment of RPG Crouch Chapman LLP as the auditors of the Company. It is normal practice for a company's directors to be authorised to agree how much the auditors should be paid and Resolution 2 grants this authority to the directors.

Resolutions 3 to 9 - Re-election of Directors

Article 77 of the Company's articles of association requires any directors who have been appointed by the Board since the last annual general meeting and any directors who were not appointed or reappointed at one of the preceding two annual general meetings to retire from office. Any such director is entitled to offer himself for re-election.

Resolutions 10 and 11 - Directors' general power to allot relevant securities

Resolution 10 is proposed to renew the directors' power to allot shares.

Resolution 10 seeks to grant the directors authority to allot, pursuant to section 551 of the Act, shares or grant rights to subscribe for or to convert any security into shares in the Company up an aggregate nominal value of £520,177 which is equal to one third of the nominal value of the current issued ordinary share capital of the Company as at 10 May 2024 (being the latest practicable date prior to the publication of this notice). Unless previously renewed, revoked or varied, the authorities sought under this resolution will expire at the conclusion of the next annual general meeting of the Company next annual general meeting of the Company to be held in 2025 or 14 September 2025 (whichever is the earlier). The Directors have no present intention of exercising either of the authorities under this resolution, but the Board wishes to ensure that the Company has maximum flexibility in managing the financial resources of the Company. As at the date of this notice, no shares are held by the Company in treasury.

Resolution 11 is to approve the partial disapplication of pre-emption rights in respect of the allotment of equity securities for cash. The passing of this resolution (together with resolution 10) would allow the directors to allot shares for cash and/or sell treasury shares without first having to offer such shares to existing shareholders in proportion to their existing holdings. The authority would be limited to allotments or sales up to an aggregate nominal amount of £78,027 which represents approximately 5 per cent. of the nominal value of the current issued ordinary share capital of the Company as at 10 May 2024 (being the latest practicable date prior to the publication of this notice). Unless previously renewed, revoked or varied, the authorities sought under this resolution will expire at the conclusion of the next annual general meeting of the Company next annual general meeting of the Company to be held in 2025 or 14 September 2025 (whichever is the earlier).

Resolution 12 - Authority for the market purchase by the Company of its own shares

The authority sought by resolution 12 limits the number of shares that could be purchased to a maximum of 3,121,060 ordinary shares (equivalent to 10 per cent. of the Company's issued ordinary share capital as at 10 May 2024 (being the latest practicable date prior to the publication of this notice)) and sets a minimum and maximum price. Unless previously renewed, revoked or varied, the authority will expire at the conclusion of the annual general meeting of the Company to be held in 2025 or 14 September 2025 (whichever is the earlier). The Directors have no present intention of exercising the authority to purchase the Company's ordinary shares but will keep the matter under review, taking into account the financial resources of the Company, the Company's share price and future funding opportunities. The Directors will exercise this authority only when to do so would be in the best interests of the Company and of its shareholders generally, and could be expected to result in an increase in earnings per share of the Company. Any purchases of ordinary shares would be by means of market purchase through the London Stock Exchange plc. Any shares the Company buys under this authority may either be cancelled or held in treasury. Treasury shares can be re-sold for cash, cancelled or used for the purposes of employee share schemes. No dividends are paid on shares whilst held in treasury and no voting rights attach to treasury shares. The Directors believe that it is desirable for the Company to have this choice as holding the purchased shares as treasury shares would give the Company the ability to re-sell or transfer them in the future and so provide the Company with additional flexibility in the management of its capital base.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FR EAKSEFFFLEFA